PER 5.26% 8.0¢ percheron therapeutics limited

Isis, Genzyme Submit Antisense Cholesterol Drug for European...

  1. 13,154 Posts.
    lightbulb Created with Sketch. 1382
    Isis, Genzyme Submit Antisense Cholesterol Drug for European Approval
    July 28, 2011

    * Type size: - +
    * ""
    * Email
    * Printer-friendly version
    * RSS Feed

    Specifically, the companies are seeking clearance to commercialize the 200 mg weekly dose of the drug for the treatment of homozygous and severe heterozygous familial hypercholesterolemia.

    Once again correct ACE.....
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.004(5.26%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $35.48K 451.2K

Buyers (Bids)

No. Vol. Price($)
1 12500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 198147 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.